Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (631-640 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Cancer Cell|October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsLydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
Cancer Cell|September 30, 2014
Gene body methylation can alter gene expression and is a therapeutic target in cancerXiaojing Yang, Han Han, Daniel D De Carvalho, et al.
Cancer Cell|September 10, 2014
Structure, function, and resistance in chronic myeloid leukemiaJerald Radich
Cancer Cell|September 10, 2014
DAISY: picking synthetic lethals from cancer genomesColm J Ryan, Christopher J Lord, Alan Ashworth
Cancer Cell|September 10, 2014
Vulnerabilities of mutant SWI/SNF complexes in cancerKatherine C Helming, Xiaofeng Wang, Charles W M Roberts
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Cancer Cell|September 10, 2014
Notch activation as a driver of osteogenic sarcomaJianning Tao, Ming-Ming Jiang, Lichun Jiang, et al.
Cancer Cell|October 15, 2014
The double life of p85Carlotta Costa, Jeffrey A Engelman
Cancer Cell|October 15, 2014
Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factorsKunyoo Shin, Agnes Lim, Chen Zhao, et al.
Pageof 410

Showing results (631-640 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Cancer Cell|October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsLydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
Cancer Cell|September 30, 2014
Gene body methylation can alter gene expression and is a therapeutic target in cancerXiaojing Yang, Han Han, Daniel D De Carvalho, et al.
Cancer Cell|September 10, 2014
Structure, function, and resistance in chronic myeloid leukemiaJerald Radich
Cancer Cell|September 10, 2014
DAISY: picking synthetic lethals from cancer genomesColm J Ryan, Christopher J Lord, Alan Ashworth
Cancer Cell|September 10, 2014
Vulnerabilities of mutant SWI/SNF complexes in cancerKatherine C Helming, Xiaofeng Wang, Charles W M Roberts
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Cancer Cell|September 10, 2014
Notch activation as a driver of osteogenic sarcomaJianning Tao, Ming-Ming Jiang, Lichun Jiang, et al.
Cancer Cell|October 15, 2014
The double life of p85Carlotta Costa, Jeffrey A Engelman
Cancer Cell|October 15, 2014
Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factorsKunyoo Shin, Agnes Lim, Chen Zhao, et al.
Pageof 410